Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A morphologic variant of papillary carcinoma of the thyroid gland characterized by the presence of pseudostratified malignant follicular cells.
Biomarker and diagnostic research for columnar cell variant thyroid gland papillary carcinoma has been reported in the published literature.
No clinical trials have been registered for columnar cell variant thyroid gland papillary carcinoma.
8 publications have been identified in PubMed for columnar cell variant thyroid gland papillary carcinoma. Research spans Case Report / Case Series (38%), Diagnostic / Biomarker (25%), and Review / Meta-Analysis (25%).
Ilic J (2026). [PMID: 41595263](https://pubmed.ncbi.nlm.nih.gov/41595263/). *Cancers (Basel)*. [Case Report / Case Series]
Zhao J (2025). [PMID: 40853492](https://pubmed.ncbi.nlm.nih.gov/40853492/). *Langenbecks Arch Surg*. [Review / Meta-Analysis]
Issin G (2025). [PMID: 41382956](https://pubmed.ncbi.nlm.nih.gov/41382956/). *Rom J Morphol Embryol*. [Case Report / Case Series]
Qi X (2025). [PMID: 40094021](https://pubmed.ncbi.nlm.nih.gov/40094021/). *Front Oncol*. [Case Report / Case Series]
Puvvadi S (2024). [PMID: 39280385](https://pubmed.ncbi.nlm.nih.gov/39280385/). *Cureus*. [Diagnostic / Biomarker]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 2:34 PM UTC
Common questions about columnar cell variant thyroid gland papillary carcinoma
Harahap AS (2024). [PMID: 39557408](https://pubmed.ncbi.nlm.nih.gov/39557408/). *J Pathol Transl Med*. [Review / Meta-Analysis]
Alshwayyat S (2024). [PMID: 39614618](https://pubmed.ncbi.nlm.nih.gov/39614618/). *Cancer Rep (Hoboken)*. [Diagnostic / Biomarker]